News
The Joint Commission Now Has a Rulebook for Hospital AI
Key takeaways
- On June 1, 2026, the Joint Commission launched RUAIH (Responsible Use of AI in Healthcare), the first voluntary certification of its kind built specifically for healthcare organizations.
- It certifies how an organization governs AI, not individual AI products, across five standard areas.
- Hospitals, critical access hospitals, and health systems can apply, whether or not they are Joint Commission accredited.
- It aligns with the Coalition for Health AI's eight open-source governance playbooks, and arrives alongside broader moves including FDA work on AI tools and tighter CMS oversight of accrediting organizations.
Hospitals have been buying AI faster than they can govern it. That just changed.
On June 1, the Joint Commission, which accredits most US hospitals, launched a certification called Responsible Use of AI in Healthcare (RUAIH). The Joint Commission says it is the first certification of its kind built specifically for healthcare organizations. It is voluntary, and a hospital does not need to be Joint Commission accredited to apply.
There is a detail that is easy to miss and worth reading carefully: the certification does not evaluate individual AI products. It certifies how an organization governs AI, meaning the policies, oversight, and processes around those tools rather than the tools themselves. Put another way, it will not tell you whether a given sepsis prediction model works. It tells you whether the hospital running that model has a workable process for deciding whether it works.
What the certification actually checks
RUAIH is built around five standard areas. The Joint Commission lists them as:
- Governance
- Effective data management
- Reducing risk and bias
- Monitoring, evaluating, and validating safety performance, efficacy, and responsible use
- Transparency, education, and training
The certification is open to hospitals, critical access hospitals, and health systems. The Joint Commission says it convened more than 20 coalitions and groups with healthcare and technology expertise to develop it. President and CEO Jonathan B. Perlin, MD, PhD, framed the goal in terms of AI's potential to drive new discoveries and improve quality, safety, and operational efficiency, with the certification meant to give organizations a blueprint for using AI safely.
The other half: shared playbooks
The certification did not arrive alone. The week before it launched, the Coalition for Health AI (CHAI), the Joint Commission’s partner on this work, released a set of open-source AI governance playbooks for health systems, developed with input from more than 100 healthcare organizations. The two are designed to line up with each other.
The CHAI playbooks break governance into eight elements, including an organizational AI policy, a responsible AI lifecycle, risk and impact assessments, third-party management, and education and training. Brian Anderson, MD, CHAI’s CEO, said the alignment between the playbooks and the certification is meant to reduce confusion and speed up responsible adoption. Aaron Miri, chief digital information officer at Baptist Health, put the need simply: hospitals need a framework to follow for this emerging technology.
The plain-language version: instead of every hospital inventing its own AI rulebook from scratch, there is now a common one to point to, and a certification that checks whether you actually follow it.
Why this lands the same week as an FDA milestone
The governance push is not happening in a vacuum. As 2 Minute Medicine noted in its June 15 AI roundup, the FDA’s Center for Drug Evaluation and Research recently accepted a letter of intent, reported by Reuters on June 3, for an AI-based, “in silico” tool designed to predict drug-induced liver injury. It works by comparing a new drug’s chemical structure against drugs with known safety profiles, and it was admitted to the FDA’s ISTAND pilot program as a first step in a longer qualification process. The stated aim is to catch safety problems earlier and lean less on animal testing.
Read together, the two stories point the same direction. AI is moving from pilot projects into the machinery of care: into how drugs get evaluated and how hospitals make decisions. The infrastructure for governing it is finally being built at the same time, instead of years behind.
One wrinkle in the background
It is worth flagging one thing happening at the same time. On June 12, CMS finalized a rule tightening its oversight of the nine accrediting organizations that survey more than 9,000 Medicare providers, a group that includes the Joint Commission. The rule moves to curb conflicts of interest, including the fee-based consulting that accreditors sell to facilities they later inspect. It does not touch the RUAIH certification, and the consulting limits were held back for another year of public comment. But it is the backdrop this certification launches into: regulators are paying closer attention to how accreditors make money on services around their core accreditation work, and a new paid, voluntary certification is the kind of adjacent product worth watching as that plays out.
Frequently asked questions
What is the Joint Commission’s RUAIH certification?
Responsible Use of AI in Healthcare (RUAIH) is a voluntary certification the Joint Commission launched on June 1, 2026. It is the first certification built exclusively for healthcare organizations, and it certifies governance and processes rather than individual AI products.
What does the certification require?
It is built around five standard areas: governance; effective data management; risk and bias reduction; monitoring, evaluating, and validating safety and performance; and transparency, education, and training.
Do you have to be Joint Commission–accredited to apply?
No. It is open to hospitals, critical access hospitals, and health systems, and an organization does not need to be Joint Commission–accredited to apply.
How does it relate to the Coalition for Health AI (CHAI)?
The week before the certification launched, CHAI released eight open-source AI governance playbooks developed with more than 100 healthcare organizations. The playbooks and the certification are designed to align.
Where we sit, and what it means on the floor
We make scrubs. We do not build clinical AI, and we are not going to pretend to grade a prediction model or tell a hospital how to run its data governance. That is not our lane. But a lot of what gets decided in these frameworks lands on the nurse standing at the bedside, so it is worth reading honestly.
A few honest takes:
- Governance is the right thing to certify first. Most AI failures in hospitals are not exotic; they are a tool quietly drifting out of accuracy with no one assigned to notice. Certifying the “who is watching this” before the “is the tool clever” is the correct order.
- “Voluntary” is the word to watch. A certification only changes practice if enough systems pursue it, or if payers and patients start asking who has it. Worth revisiting in a year to see how many hospitals actually sign up.
- The standard names education and training for a reason. A model is only as safe as the person deciding whether to trust its output at 3 a.m. If the rollout reaches the bedside as a black box, the governance on paper won’t hold.
None of this is ours to certify. But the floor is where it all gets tested, and that is the world we build for. You can see how we think about it across our scrubs.
Sources: The Joint Commission press release on the Responsible Use of AI in Healthcare certification (June 1, 2026); Coalition for Health AI governance playbooks; 2 Minute Medicine AI Roundup (June 15, 2026); Reuters reporting on the FDA ISTAND liver-injury tool (June 3, 2026); CMS final rule strengthening oversight of accrediting organizations (June 12, 2026).
Edited by Hedy Nie, COO of Eipnare. Connect on LinkedIn.